Picard Medical, Inc. (PMI)

Picard Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec 31, 2025	Dec 31, 2024
Net Income	-27	-21.06
Depreciation & Amortization	0.16	0.23
Stock-Based Compensation	0.75	0.89
Other Adjustments	13.61	7.11
Change in Receivables	-0.12	0.12
Changes in Inventories	0.39	-1.33
Changes in Accounts Payable	-3.21	2.21
Changes in Accrued Expenses	0.36	0.35
Changes in Other Operating Activities	-0.62	-0.38
Operating Cash Flow	-15.67	-11.87
Long-Term Debt Issued	19.41	13.12
Long-Term Debt Repaid	-8.22	-1.32
Net Long-Term Debt Issued (Repaid)	11.19	11.8
Issuance of Common Stock	17.44	-
Net Common Stock Issued (Repurchased)	17.44	-
Other Financing Activities	-1.56	-0.06
Financing Cash Flow	27.08	11.74
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.05	-0.02
Net Cash Flow	11.36	-0.15
Free Cash Flow	-15.67	-11.87
FCF Margin	-317.27%	-270.42%
Free Cash Flow Per Share	-0.43	-1.49
Levered Free Cash Flow	-18.73	-10.87
Unlevered Free Cash Flow	-16.19	-12.63

Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q